Old Web
English
Sign In
Acemap
>
authorDetail
>
Anil Kamat
Anil Kamat
Medicine
Adverse effect
Oncology
Pathology
Refractory Chronic Lymphocytic Leukemia
4
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pioneering commercial CAR T cell therapy clinical development in India and South Asia
2021
Anil Kamat
Show All
Source
Cite
Save
Citations (0)
Dynamic causal modeling for EEG during complex laparoscopic skill acquisition
2021
Pushpinder Walia
Anil Kamat
Suvranu De
Anirban Dutta
Show All
Source
Cite
Save
Citations (1)
Retrospective post-marketing study on the use of bio-similar pegasparagase among acute lymphoblastic leukemia patients in India
2018
Pediatric Hematology Oncology Journal
Anil Kamat
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of ibrutinib in indian patients with relapsed or refractory chronic lymphocytic leukemia and mantle cell lymphoma: Cases from a named patient program
2017
Indian Journal of Medical and Paediatric Oncology
MohanB Agarwal
Dinesh Bhurani
Chirag Shah
Nitin Sood
Manish Singhal
Anil Kamat
Subash Chezhian
Suryaprakash Mishra
Dinesh Nagrale
Show All
Source
Cite
Save
Citations (4)
1